- Titan Pharmaceuticals
Titan Pharmaceuticals, Inc. is a
California biopharmaceutical company. Titan develops proprietary therapeutics for the treatment ofcentral nervous system disorders,cardiovascular disease ,bone disease , and other disorders primarily in theUnited States . Its products in development includeprobuphine , inPhase III clinical trials for the treatment ofopioid dependence;iloperidone , in Phase III for the treatment ofschizophrenia and related psychotic disorders; andspheramine , in Phase IIb for the treatment of advancedParkinson’s disease . The company’s potential products also include DITPA, in Phase II for the treatment of congestive heart failure and hyperlipidemia; andgallium maltolate , in Phase I for the treatment of bone related diseases, chronic bacterial infections, and cancer.Titan has a strategic alliance with Schering AG for the development of spheramine and Vanda Pharmaceuticals, Inc. for the development of iloperidone. Titan Pharmaceuticals was founded by Louis R. Bucalo. [ [http://www.bizjournals.com/gen/executive.html?excode=7814DDD61306493D959AD45A75DA26D9 Louis R. Bucalo] ] The company was incorporated in 1992 and is based in
South San Francisco , California.References
External links
* [http://titanpharm.com Titan Pharmaceuticals website]
Wikimedia Foundation. 2010.